Neoadjuvant nivolumab plus ipilimumab in microsatellite instability-high (MSI-H)/deficient mismatch repair (dMMR) rectal tumors: ECOG-ACRIN EA2201

被引：0

作者：

Ciombor, K. K. ^{[1
]}

Hong, S. ^{[2
]}

Eng, C. ^{[3
]}

Yao, X. ^{[4
]}

You, N. ^{[5
]}

Das, P. ^{[6
]}

Chakravarthy, A. ^{[7
]}

O'Dwyer, P. J. ^{[8
]}

机构：

[1] Vanderbilt Univ, Med Ctr, Internal Med Hematol Oncol Dept, Preston Canc Res Bldg, Nashville, TN USA

[2] Dana Farber Canc Inst, Data Sci, Boston, MA USA

[3] Vanderbilt Ingram Canc Ctr, Hematol Oncol Dept, Nashville, TN USA

[4] Cleveland Clin Florida, Oncol, Weston, FL USA

[5] Univ Texas MD Anderson Canc Ctr, Colorectal Surg, Houston, TX USA

[6] Univ Texas MD Anderson Canc Ctr, Radiol Oncol, Houston, TX USA

[7] Vanderbilt Univ, Med Ctr, Radiat Oncol, Nashville, TN USA

[8] ECOG ACRIN Canc Res Grp, Med Oncol Dept, Philadelphia, PA USA

来源：

ANNALS OF ONCOLOGY | 2024年 / 35卷

关键词：

D O I：

10.1016/j.annonc.2024.05.249

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

242MO

引用

页码：S104 / S104

页数：1

共 50 条

[21] Pembrolizumab in microsatellite instability-high/mismatch repair deficient (MSI-H/dMMR) and non-MSI-H/non-dMMR advanced endometrial cancer: Phase 2 KEYNOTE-158 study results
O'Malley, David M.
Bariani, Giovani M.
Cassier, Philippe A.
Marabelle, Aurelien
Hansen, Aaron R.
Acosta, Ana De Jesus
Miller Jr, Wilson H.
Safra, Tamar
Italiano, Antoine
Mileshkin, Linda
Yao, Lili
Gozma, Alexander
Jin, Fan
Maio, Michele
GYNECOLOGIC ONCOLOGY, 2025, 193 : 130 - 135
[22] ONCOLOGISTS' PERCEPTIONS OF NIVOLUMAB PLUS IPILUMUMAB (NIVO plus IPI) AS FIRST-LINE (1L) TREATMENT FOR MICROSATELLITE INSTABILITY-HIGH/MISMATCH REPAIR-DEFICIENT (MSI-H/DMMR) METASTATIC COLORECTAL CANCER (MCRC)
Emidio, O.
Iqbal, Z.
Jeune-Smith, Y.
Feinberg, B.
VALUE IN HEALTH, 2024, 27 (12) : S351 - S351
[23] Nivolumab (NIVO) plus low-dose ipilimumab (IPI) in previously treated patients (pts) with microsatellite instability-high/mismatch repair-deficient (MSI-H/dMMR) metastatic colorectal cancer (mCRC): Long-term follow-up.
Overman, Michael J.
Lonardi, Sara
Wong, Ka Yeung Mark
Lenz, Heinz-Josef
Gelsomino, Fabio
Aglietta, Massimo
Morse, Michael
Van Cutsem, Eric
McDermott, Raymond S.
Hill, Andrew G.
Sawyer, Michael B.
Hendlisz, Alain
Neyns, Bart
Svrcek, Magali
Atasoy, Ajlan
Zhao, Huanyu
Lei, Ming
Kopetz, Scott
Andre, Thierry
JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (04)
[24] An unusual case of microsatellite instability-high/deficient mismatch repair (MSI-H/dMMR) diffuse large B-cell lymphoma revealed by targeted gene sequencing
Han, Bogyeong
Kim, Sehui
Koh, Jiwon
Bae, Jeong Mo
Yun, Hongseok
Jeon, Yoon Kyung
JOURNAL OF PATHOLOGY AND TRANSLATIONAL MEDICINE, 2022, 56 (02) : 92 - 96
[25] Nivolumab (NIVO) plus low-dose ipilimumab (IPI) as first-line (1L) therapy in microsatellite instability-high/DNA mismatch repair deficient (MSI-H/dMMR) metastatic colorectal cancer (mCRC): Clinical update.
Lenz, Heinz-Josef
Lonardi, Sara
Zagonel, Vittorina
Van Cutsem, Eric
Limon, M. Luisa
Wong, Ka Yeung Mark
Hendlisz, Alain
Aglietta, Massimo
Garcia-Alfonso, Pilar
Neyns, Bart
Cardin, Dana Backlund
Spallanzani, Andrea
Dragovich, Tomislav
Shah, Usman
Atasoy, Ajlan
Ledeine, Jean-Marie
Overman, Michael J.
JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
[26] Neoadjuvant Nivolumab Plus Ipilimumab and Adjuvant Nivolumab in Localized Deficient Mismatch Repair/Microsatellite Instability-High Gastric or Esophagogastric Junction Adenocarcinoma: The GERCOR NEONIPIGA Phase II Study
Andre, Thierry
Tougeron, David
Piessen, Guillaume
de la Fouchardiere, Christelle
Louvet, Christophe
Adenis, Antoine
Jary, Marine
Tournigand, Christophe
Aparicio, Thomas
Desrame, Jerome
Lievre, Astrid
Garcia-Larnicol, Marie-Line
Pudlarz, Thomas
Cohen, Romain
Memmi, Salome
Vernerey, Dewi
Henriques, Julie
Lefevre, Jeremie H.
Svrcek, Magali
JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (02) : 255 - +
[27] Dostarlimab in advanced/recurrent (A/R) mismatch repair deficient/microsatellite instability-high or proficient/stable (dMMR/MSI-H or MMRp/MSS) endometrial cancer (EC): the GARNET study
Oaknin, Ana
Pothuri, Bhavana
Gilbert, Lucy
Sabatier, Renaud
Ghamande, Sharad
Gravina, Adriano
Calvo, Emiliano
Banerjee, Susana
Mangan, Niamh
Miller, Rowan E.
Pikiel, Joanna
Mirza, Mansoor R.
Duan, Tao
Zildjian, Sybil
Zografos, Eleftherios
Veneris, Jennifer
Tinker, Anna V.
ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2022, 18 : 133 - 134
[28] Durable Clinical Benefit With Nivolumab Plus Ipilimumab in DNA Mismatch Repair-Deficient/Microsatellite Instability-High Metastatic Colorectal Cancer
Overman, Michael J.
Lonardi, Sara
Wong, Ka Yeung Mark
Lenz, Heinz-Josef
Gelsomino, Fabio
Aglietta, Massimo
Morse, Michael A.
Van Cutsem, Eric
McDermott, Ray
Hill, Andrew
Sawyer, Michael B.
Hendlisz, Alain
Neyns, Bart
Svrcek, Magali
Moss, Rebecca A.
Ledeine, Jean-Marie
Cao, Z. Alexander
Kamble, Shital
Kopetz, Scott
Andre, Thierry
JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (08) : 773 - +
[29] Impact of RAS mutations on immunologic characteristics of the tumor microenvironment (TME) in patients with microsatellite instability-high (MSI-H) or mismatch-repair-deficient (dMMR) colorectal cancer (CRC).
Salem, Mohamed E.
Andre, Thierry
El-Refai, Sherif Mohamed
Kopetz, Scott
Tabernero, Josep
Sinicrope, Frank A.
Tie, Jeanne
George, Thomas J.
VanCutsem, Eric
Mauer, Elizabeth
Lonardi, Sara
Overman, Michael J.
Foureau, David
JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
[30] PEMBROLIZUMAB MONOTHERAPY FOR MICROSATELLITE INSTABILITY-HIGH (MSI-H) OR MISMATCH REPAIR DEFICIENT (DMMR) RECURRENT GLIOMAS: RESULTS FROM THE MULTICOHORT PHASE 2 KEYNOTE-158 STUDY
Baldini, Capucine
Cassier, Philippe A.
Delord, Jean-Pierre
Simonelli, Matteo
Touat, Mehdi
Yao, Lili
Duic, J. Paul
Gozman, Alexander
Marabelle, Aurelien
NEURO-ONCOLOGY, 2022, 24 : 59 - 60

← 1 2 3 4 5 →